Bayer Awards $2 Million in Grants to Hemophilia Research and Patient Care

Jul 11, 2017
By Pharmaceutical Executive Editors
Bayer has awarded grants totaling more than $2 million to 16 recipients across eight countries as part of its Bayer Hemophilia Awards Program (BHAP).
 
Four U.S. clinicians and researchers from the Children's Hospital of Philadelphia and Uniformed Services University of the Health Sciences in Maryland are among the winners. Grant recipients were announced last night during a reception at the International Society on Thrombosis and Hemostasis (ISTH) 2017 Congress, Berlin, Germany.
 
The BHAP grants will support research into a broad range of projects, including anxiety among female carriers of hemophilia, FVIII splicing-switching molecules for tailored hemophilia A therapies, and the assessment of therapeutic relationships in hemophilia care. The U.S. BHAP winners are:
  • Ai-Hong Zhang, Ph.D., Uniformed Services University of the Health Sciences, Bethesda
  • Bhavya Doshi, M.D., Children's Hospital of Philadelphia
  • Manjunath Goolyam Basavaraj, Ph.D., Children's Hospital of Philadelphia
  • Paris Margaritis, DPhil., Children's Hospital of Philadelphia.
The BHAP award recipients are selected by a global panel of hemophilia clinicians, researchers and caregivers. To date, BHAP has awarded more than 280 grants, totaling more than $33 million, to researchers and caregivers from 32 countries around the world and contributed to more than 400 publications, poster presentations and other scientific communications by awardees.
 
To learn more about BHAP, visit the website.
 
native1_300x100
lorem ipsum